Ginseng Saponin Enriched in Rh1 and Rg2 Ameliorates Nonalcoholic Fatty Liver Disease by Inhibiting Inflammasome Activation - Wang, Feng; Park, Jeong-Su; Ma, Yuanqiang; Ma, Hwan; Lee, Yeo-Jin; Lee, Gyu-Rim; Yoo, Hwan-Soo; Hong, Jin-Tae; Roh, Yoon-Seok (Nutrients, 2021)
Keywords: Animals; Autophagy; Cytokines; Diet; Disease Models, Animal; fast foods; Fast Foods - adverse effects; Fatty liver; fibrosis; ginsenosides; Ginsenosides - pharmacology; hepatocytes; Hepatocytes - drug effects; Homeostasis; inflammasomes; Inflammasomes - antagonists & inhibitors; Inflammation; Laboratory animals; Lipid peroxidation; Lipids; liver; Liver - drug effects; Liver cancer; Liver diseases; Male; medicinal properties; Mice; Mice, Inbred C57BL; Mitochondrial DNA; mitophagy; Non-alcoholic Fatty Liver Disease - drug therapy; Non-alcoholic Fatty Liver Disease - etiology; Panax - chemistry; Panax notoginseng; Pathogens; Plant Extracts - pharmacology; Proteins; Saponins - pharmacology; therapeutics; United States--US; Japan; NAFLD; mitophagy; ginsenosides; inflammasome